Biological Mechanisms of Polyphenols against Clostridium Difficile: A Systematic Review
Authors:
- 1 January 2025
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Infectious Disorders - Drug Targets
- Vol. 25 (3) , 1-14
Abstract
Background: Clostridium difficile is an opportunistic infection that can lead to antibi-otic-associated diarrhea and toxic megacolon. Objective: This systematic review study aimed to investigate polyphenols' antibacterial and anti-toxin properties and their effects on reducing complications related to C. difficile Infections (CDI). Methods: This systematic review was conducted following the PRISMA guideline 2020. Multiple databases, including Web of Science, PubMed, Cochrane Library, EMBASE, and Scopus, were searched thoroughly for existing literature. After considering the inclusion and exclusion criteria for the review, 18 articles were included. Data were collected and registered into an Excel file for further investigations and conclusions. Results: Polyphenols by reducing Reactive Oxygen Species (ROS) levels, increasing inflammatory factor Interleukin 10 (IL-10), reducing Nuclear Factor kappa B (NF-κB) and Tumour Necrosis Fac-tor-α (TNF-α), IL-6, IL-1α, IL-1β, Granulocyte Colony-stimulating Factor (G-CSF), and Monocyte Chemoattractant Protein-1 (MCP-1) and Macrophage Inflammatory Protein-1 alpha (MIP-1α) lev-els, and regulating the expression of Bcl-2 and Bax, make the growth and replication conditions of C. difficile more difficult and prevent it from producing toxins. Furthermore, polyphenols can ex-hibit prebiotic properties, promoting the growth of beneficial Bifidobacterium and Lactobacillus species and consequently regulating gut microbiota, exerting antimicrobial activities against C. dif-ficile. They also induce their beneficial effects by inhibiting the production of C. difficile TcdA and TcdB. Conclusion: Polyphenols have been reported to inhibit C. difficile growth and toxin production by several mechanisms in preclinical studies. However, more clinical studies are needed to investigate their safety in humans.Keywords
This publication has 85 references indexed in Scilit:
- Clostridium difficile infection and gut microbiota: From fundamentals to microbiota-centered strategies2023
- Polyphenols against infectious diseases: Controlled release nano-formulationsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2021
- Phenolic Compounds Promote Diversity of Gut Microbiota and Maintain Colonic HealthDigestive Diseases and Sciences, 2020
- Inhibition of Bacteroidetes and Firmicutes by select phytochemicalsAnaerobe, 2020
- Targeting Carbohydrates and Polyphenols for a Healthy Microbiome and Healthy WeightCurrent Nutrition Reports, 2019
- Clostridium difficile infection: reviewEuropean Journal of Clinical Microbiology & Infectious Diseases, 2019
- Novel Insight from Computational Virtual Screening Depict the Binding Potential of Selected Phytotherapeutics Against Probable Drug Targets of Clostridium difficileInterdisciplinary Sciences: Computational Life Sciences, 2017
- Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effectsCurrent Opinion in Food Science, 2016
- Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled TrialClinical Gastroenterology and Hepatology, 2015
- US assessment of estrogen-responsive organ growth among healthy term infants: piloting methods for assessing estrogenic activityPediatric Radiology, 2010